It only makes sense that the company should have applied for a late breaking session for CVD in November. The fact that it was not announced is disturbing to me. Even the CVD will be presented at the AHA conference and they failed the endpoint,... one would have thought we would be presenting for CVD at the associated conference.
I wonder if IR would answer why no news there,...?